These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 26992218)
1. Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma. Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q Oncotarget; 2016 May; 7(18):25350-65. PubMed ID: 26992218 [TBL] [Abstract][Full Text] [Related]
2. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma. Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a. Liu F; Yuan JH; Huang JF; Yang F; Wang TT; Ma JZ; Zhang L; Zhou CC; Wang F; Yu J; Zhou WP; Sun SH Oncogene; 2016 Oct; 35(41):5422-5434. PubMed ID: 27065331 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494 [TBL] [Abstract][Full Text] [Related]
5. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364 [TBL] [Abstract][Full Text] [Related]
6. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma. Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Li Y; Liu G; Li X; Dong H; Xiao W; Lu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383 [TBL] [Abstract][Full Text] [Related]
8. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression. Zhao Q; Li T; Qi J; Liu J; Qin C PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway. Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321 [TBL] [Abstract][Full Text] [Related]
10. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214. Huang X; Gao Y; Qin J; Lu S Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358 [TBL] [Abstract][Full Text] [Related]
11. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma. Ye Y; Guo J; Xiao P; Ning J; Zhang R; Liu P; Yu W; Xu L; Zhao Y; Yu J Cancer Lett; 2020 Jan; 469():310-322. PubMed ID: 31705929 [TBL] [Abstract][Full Text] [Related]
12. [LncRNA HULC promots HCC growth by downregulating miR-29]. Zhu LR; Feng JL; Liu XJ; Wang JM Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855 [No Abstract] [Full Text] [Related]
13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1. Wang YG; Wang T; Shi M; Zhai B J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290 [TBL] [Abstract][Full Text] [Related]
15. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression. Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047 [TBL] [Abstract][Full Text] [Related]
19. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells. Li B; Mao R; Liu C; Zhang W; Tang Y; Guo Z Life Sci; 2018 Mar; 197():122-129. PubMed ID: 29421439 [TBL] [Abstract][Full Text] [Related]
20. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis. Wang YG; Liu J; Shi M; Chen FX J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]